LINDA PONCE: Open Payments
NPI 1972296408 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 28 payments from 10 companies in 2025. Trend: 2023 $146 · 2024 $709 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 9 | $172 |
| Actelion Pharmaceuticals US, Inc. | 3 | $80 |
| Baxter Healthcare | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Astellas Pharma US Inc | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Grifols USA, LLC | 2 | $39 |
| ABBVIE INC. | 2 | $30 |
| Shionogi Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Tyvaso, Hillrom - Vest System Model 105 Home Care, OPSUMIT, Cresemba, ARALAST, DUPIXENT, Prolastin-C Liquid, GLASSIA.
Industry payments across TX — which companies pay providers there.
